KELLIE GARDNER: Open Payments
NPI 1841634847 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 28 payments from 18 companies in 2025. Trend: 2023 $94 · 2024 $267 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 3 | $191 |
| Caris MPI, Inc. | 1 | $191 |
| E.R. Squibb & Sons, L.L.C. | 2 | $152 |
| BeOne Medicines USA, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| ABBVIE INC. | 2 | $63 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $42 |
| Exelixis Inc. | 1 | $34 |
| Genmab U.S., Inc. | 1 | $31 |
Products named: MI CANCER SEEK, OPDIVO, Tecentriq, Epkinly, TEVIMBRA, KEYTRUDA, CABOMETYX, ELAHERE.
Industry payments across DC — which companies pay providers there.
